Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: August 10, 2022

Details for Patent: 6,610,327

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Summary for Patent: 6,610,327
Title: Pharmaceutical moxifloxacin preparation
Abstract:The present invention relates to a pharmaceutical preparation for oral administration which comprises moxifloxacin, its salt and/or hydrate and lactose, to a process for its preparation, and to the use of this preparation for controlling bacterial infections in humans and animals.
Inventor(s): Bosche; Patrick (Odenthal, DE), Mahler; Hans Friedrich (Koln, DE), Weisemann; Claus (Apex, NC)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:09/830,770
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Formulation; Use;

Drugs Protected by US Patent 6,610,327

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,610,327

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany198 55 758Nov 10, 1998
PCT Information
PCT FiledOctober 29, 1999PCT Application Number:PCT/EP99/08230
PCT Publication Date:May 18, 2000PCT Publication Number: WO00/27398

International Family Members for US Patent 6,610,327

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 021074 See Plans and Pricing
Austria 279193 See Plans and Pricing
Australia 1267400 See Plans and Pricing
Australia 745282 See Plans and Pricing
Bulgaria 105459 See Plans and Pricing
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.